Online Pet Medications & Pet Supplies

EQUIP EHV INJ 10X1DOSE

   Product Ref: DUEQU11 Category: C

£ 315.20


Vat Rate: 20%

Prescription Required



For active immunisation of horses to reduce clinical signs due to infection with Equine Herpesvirus 1 and 4 and to reduce abortion caused by EHV-1 infection.
Vat Rate: 20%

Our Standard Delivery - £6.75

Royal Mail Tracked 24 (Signed For)

  • Next business day service
  • Compensation cover up to £100
  • Signature on delivery

 

Any orders placed after close of business on Thursday will not be delivered until Tuesday

 

 

 

Our Express Delivery - £10.45

Royal Mail Special Delivery Guaranteed by 1pm

  • Next business day service
  • Insured up to £500
  • Signature on delivery

 

Please note that all chilled deliveries must be sent on an Express service.

Chilled orders placed after close of business on Wednesday will not be despatched until Monday

You must be logged in to write review
Category POM-V
Temperature Refrigerated
MA/VM/EU No: 42058/4060
Species
  • horses
VMD Link https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_112986.PDF
NOAH Link
Dosage One dose per horse to be administered by deep intramuscular injection. Primary course A single dose should be administered from 5 months of age followed by a second injection after an interval of 4-6 weeks. In the event of increased infection risk, for example when a foal has consumed insufficient colostrum or there is a risk of early exposure to field infections with EHV-1 or EHV-4, earlier vaccination may be given. In these circumstances the foal should receive a single dose from 3 months of age followed by the above mentioned full primary vaccination course. Booster Following completion of the primary course, a single dose should be administered every 6 months. Use in pregnant mares To reduce abortion due to EHV-1 infection, pregnant mares should be vaccinated during the 5th, 7th and 9th month of pregnancy with a single 1.5 ml dose on each occasion.
Withdrawals Do not vaccinate unhealthy horses. Can be used during pregnancy. No information is available on the compatibility of this vaccine with any other. Therefore the safety and efficacy of this product when used with any other (either when used on the same day or at different times) has not been demonstrated. Do not mix with any other medicinal product. The vaccine may not be effective in animals incubating the disease at the time of vaccination. In the event of an allergic or anaphylactic reaction, immediate treatment should be given with a soluble glucocorticoid intravenously (e.g. dexamethasone sodium phosphate), adrenaline intramuscularly or anti-histamine intramuscularly. Animals that have received immunosuppressive drugs (e.g. glucocorticoids) should not be vaccinated until an interval of at least 4 weeks has elapsed. Syringes and needles should not have been sterilised chemically or be above ambient temperature. Do not use chemicals to disinfect or sterilise the skin. Shake well before use. Aseptic precautions should be observed. Adverse Reactions A transient local swelling at the injection site was very commonly observed. Usually, the local swelling does not measure more than 5 cm in diameter and disappears within a few to 6 days post vaccination. A transient increase in rectal temperature during up to 2 days following dosing not exceeding 1.7